（文章来源：证券日报） 证券日报网讯国脉科技8月18日在互动平台回答投资者提问时表示，公司持续跟踪国内外主流脑机接口 项目的进展情况，并积极开展相关研究。如达到商用条件，公司将紧贴市场需求适时推出相应的服务与 产品，并根据项目具体情况选择适合的合作伙伴。 ...

Group 1 - The Shanghai Composite Index reached a ten-year high of 3745.94 points on August 18, indicating a significant influx of capital into the A-share market, with trading volume exceeding 2 trillion yuan in recent days, peaking at over 2.7 trillion yuan on the 18th [1] - In July, A-shares saw 1.9636 million new accounts opened, a year-on-year increase of over 70%, reflecting growing investor interest [1] - The decrease of 1.1 trillion yuan in household deposits in July, compared to a larger decline of 780 billion yuan year-on-year, alongside a 2.14 trillion yuan increase in non-bank institutional deposits, suggests a shift in capital flow towards the stock market [1] Group 2 - The difficulty of stock selection is increasing, requiring higher levels of professional knowledge from investors, as there are over 5400 listed companies in the A-share market, with 1861 listed after 2020 [3] - Traditional stock selection logic based on consumer familiarity is becoming less applicable, as many sectors have matured, and innovative fields like chips, innovative drugs, AI, and humanoid robots are gaining investor interest [3] - Investors may find it beneficial to participate in A-share investments indirectly through funds or ETFs to manage risks while seizing investment opportunities [3] Group 3 - New investors often enter the market during bullish trends, leading to a false sense of ease in making profits, which can result in aggressive trading behavior [4] - The "newbie welfare period" is typically short-lived, and understanding economic, industry, and corporate development rules is essential for long-term wealth growth in the stock market [4]

证券日报网讯陇神戎发8月18日在互动平台回答投资者提问时表示，公司聚焦于中药研发、生产与销售 业务，目前无脑机接口领域相关业务和拓展计划。 （文章来源：证券日报） ...

上证指数创10年新高，成交额突破2.8万亿。 忽如一夜春风来，千股万股梨花开。 此外，2025西普会（健康产业生态大会）的核心论坛"AI for Health高峰论坛"于8月18日至19日在海南博鳌启幕，或为AI医疗行业带来更多催化。 市场高度关注脑机接口、可穿戴医疗设备、AI医疗诊断、AI制药研发等细分领域投资机会。 很多踏空的朋友可能会很焦虑，坊间也一直流传着牛市旗手买券商的说法。 那前期持续火爆的创新药该何去何从？ AI for Health高峰论坛开幕，AI医疗持续火热，京东健康(HK6618)大涨。 8月18日，京东健康等AI医疗概念股持续火热，盘中一度涨超10%。 据此前公告，京东健康的日均在线问诊量超50万，H1营收353亿，净利润增长35%，远超预期。 医保局未来或支持脑机接口快速进入临床应用并收费； 随着AI技术的突破，AI医疗、AI制药等领域也取得了较多突破性研发进展。 FDA于7月批准了首款AI可穿戴治疗设备； 微软推出革命性AI医疗诊断系统； 晶泰控股在8月初公告与DoveTree达成总额约470亿港元（59.9亿美元）的管线合作，创下全球AI药物发现领域单笔合作金额的记录。 跟踪港股 ...

Market Overview - On August 18, the A-share market reached a historic milestone, with the total market capitalization of A-share companies surpassing 100 trillion yuan for the first time, setting a new record [1] - By the close of trading, the Shanghai Composite Index rose by 0.85% to 3728.03 points, marking the highest intraday level since August 20, 2015. The ChiNext Index surged by 2.84%, and the Shenzhen Component Index increased by 1.73% [2] Sector Performance - Key sectors such as liquid cooling servers, film and television, technology innovation, and 5G saw gains exceeding 4%, indicating strong momentum in technology and related fields [2] - The liquid cooling server sector led with a rise of 6.31%, followed by the film and television sector at 5.88%, and technology innovation stocks at 5.51% [3] Brokerage Sector Highlights - The brokerage sector emerged as a focal point of the market, with significant gains. Notable stocks included Changcheng Securities, Huayin Securities, and Xichuan Securities, which all experienced substantial price increases [3] - Recent positive developments in the brokerage sector include strong earnings reports, with several firms reporting net profit growth exceeding 25% year-on-year for the first half of 2025. Expectations for larger brokerages' performance are also optimistic, with projected net profit growth of 61.23% [4] M&A Activity - The brokerage sector is witnessing increased merger and acquisition activity, with the China Securities Regulatory Commission approving West Securities as the major shareholder of Guorong Securities. This trend is expected to continue, with several other significant transactions having occurred earlier this year [4] Investment Direction - Following the bullish momentum in the brokerage sector, future capital flows and investment directions are under scrutiny. Potential areas of focus include technology sectors such as consumer electronics, autonomous driving, domestic computing power, and AI software, as well as new consumption trends and thematic investments like commercial aerospace and brain-computer interfaces [5]

Investment Rating - The industry investment rating is "Outperform" [2] Core Insights - The report highlights the issuance of the "Implementation Opinions on Promoting the Innovation and Development of Brain-Machine Interface Industry" by the Ministry of Industry and Information Technology and six other departments, which increases certainty in the related industry [5][14] - The pharmaceutical and biotechnology sector has shown a 3.08% increase this week, outperforming the CSI 300 index by 0.7 percentage points, ranking 10th among 31 sub-industries [20][21] - The report indicates that the brain-machine interface technology is in a period of accelerated transformation, with domestic companies expected to gradually achieve commercialization, leading to rapid market expansion [6][17] Summary by Sections Industry Overview - The closing index for the industry is 9029.09, with a 52-week high of 9029.09 and a low of 6070.89 [2] Weekly Performance - The medical research outsourcing sector had the highest increase this week at 7.77%, followed by the hospital sector at 5.59% and medical consumables at 4.47% [7][21] - The report notes a significant divergence in performance among sub-sectors, with offline pharmacies experiencing the largest decline at 1.82% [7][21] Beneficiary Stocks - Beneficiary stocks in the innovative drug sector include companies such as Innovent Biologics, Kintor Pharmaceutical, and BeiGene for H-shares, and Zai Lab, Eucure Biopharma, and others for A-shares [8] - In the medical device and consumables sector, companies like Mindray Medical, Weigao Group, and others are highlighted as beneficiaries [8] Sub-sector Analysis - The report emphasizes that the innovative drug sector is expected to continue performing well due to overseas business development expectations and supportive policy documents [26] - The medical device sector is projected to benefit from policies promoting the replacement of old equipment, with significant growth expected in the second quarter of 2025 [27][28] - The IVD sector is anticipated to see marginal improvements due to optimized procurement policies, with AI-assisted diagnostics being a promising direction [31][32] Market Trends - The report indicates that the overall trend for the medical device industry is positive, driven by innovation, mergers, and internationalization, with leading Chinese companies expected to grow into global leaders [28] - The report also notes that the traditional Chinese medicine sector is expected to see a turning point as inventory clears and procurement policies are implemented [40]

Group 1 - The core viewpoint is that brain-computer interfaces are advancing rapidly towards industrialization, with government support and policy measures in place to foster innovation and commercialization in the medical and health sectors by 2027 and 2030 [1] - The Ministry of Industry and Information Technology and six other departments aim to break through key technologies by 2027 and cultivate global leading enterprises by 2030, establishing a competitive industrial ecosystem [1] - Continuous technological innovation and clear policy support are expected to accelerate the commercialization of domestic enterprises in the brain-computer interface sector [1] Group 2 - The pharmaceutical and biotechnology sectors are benefiting from ongoing policy encouragement for innovative devices, with specific segments like insulin and orthopedics expected to see new growth due to optimized procurement policies [1] - The industry is currently experiencing a period of increased concentration, with heightened expectations for mergers and acquisitions [1] - The Guotai ETF (159377) tracks the Chuangyi Pharmaceutical Index (399275), which focuses on innovative biopharmaceuticals and can experience daily fluctuations of up to 20% [1]

每经AI快讯，有投资者在投资者互动平台提问：董秘你好，请问公司有参股脑机接口相关公司吗？公 司是否涉及体育类动作捕捉设备生产开发？ 金陵体育（300651.SZ）8月18日在投资者互动平台表示，没有参股脑机接口的相关公司，公司运营的金 陵篮球公园有配置体育类动作捕捉设备。 （文章来源：每日经济新闻） ...

每经AI快讯，有投资者在投资者互动平台提问：董秘你好，康复产业（西安）创新中心已经成立一 年，公司的康复机器人和脑机接口项目进展如何 新华医疗（600587.SH）8月18日在投资者互动平台表示，公司康复机器人系列产品已完成产品设计， 现处于样机研发与试制阶段；公司正有序推进脑机接口技术的前期调研工作。 （文章来源：每日经济新闻） ...

Investment Rating - The report maintains an "Outperform" rating for the computer industry, expecting a relative return exceeding the benchmark index by over 10% in the next 12-18 months [5][27]. Core Insights - The Ministry of Industry and Information Technology has issued guidelines to promote the development of the brain-computer interface industry, which is expected to enhance high-quality growth and innovation [10]. - The release of GPT-5 on August 8, 2025, has significantly reduced costs and is anticipated to benefit AI applications in the long term, accelerating the implementation of AI technologies [9][11]. - The World Robot Conference, held from August 8-12, 2025, showcases advancements in robotics and AI, featuring over 200 companies and focusing on embodied intelligence applications across various sectors [12]. Summary by Sections Industry Development - The guidelines aim for breakthroughs in key technologies by 2027, establishing a secure industry system by 2030 with 2-3 globally influential enterprises and a competitive ecosystem [10]. GPT-5 Release - GPT-5 has shown improvements in reliability, efficiency, and cost, with a 45% reduction in hallucination rates compared to GPT-4 and an 80% reduction compared to OpenAI o3, enhancing its practical applications in software development and content production [11]. - The context processing capability of GPT-5 supports 400k tokens, doubling the accuracy of long-text generation compared to previous versions [11]. Recommended Stocks - The report recommends focusing on companies such as Kingdee International, Kingsoft Office, Hand Enterprise, and others, which are expected to benefit from the positive outlook in the computer sector [5][9].